460 related articles for article (PubMed ID: 28534511)
1. Stromal-derived IGF2 promotes colon cancer progression via paracrine and autocrine mechanisms.
Unger C; Kramer N; Unterleuthner D; Scherzer M; Burian A; Rudisch A; Stadler M; Schlederer M; Lenhardt D; Riedl A; Walter S; Wernitznig A; Kenner L; Hengstschläger M; Schüler J; Sommergruber W; Dolznig H
Oncogene; 2017 Sep; 36(38):5341-5355. PubMed ID: 28534511
[TBL] [Abstract][Full Text] [Related]
2. Autocrine WNT2 signaling in fibroblasts promotes colorectal cancer progression.
Kramer N; Schmöllerl J; Unger C; Nivarthi H; Rudisch A; Unterleuthner D; Scherzer M; Riedl A; Artaker M; Crncec I; Lenhardt D; Schwarz T; Prieler B; Han X; Hengstschläger M; Schüler J; Eferl R; Moriggl R; Sommergruber W; Dolznig H
Oncogene; 2017 Sep; 36(39):5460-5472. PubMed ID: 28553956
[TBL] [Abstract][Full Text] [Related]
3. Cancer-associated fibroblasts potentiate colorectal cancer progression by crosstalk of the IGF2-IGF1R and Hippo-YAP1 signaling pathways.
Zhang J; Chen B; Li H; Wang Y; Liu X; Wong KY; Chan WN; Chan AK; Cheung AH; Leung KT; Dong Y; Pan Y; Ke H; Liang L; Zhou Z; Xiao J; Wong CC; Wu WK; Cheng AS; Ma BB; Yu J; Lo KW; Kang W;
J Pathol; 2023 Feb; 259(2):205-219. PubMed ID: 36373776
[TBL] [Abstract][Full Text] [Related]
4. Insulin-Like Growth Factor 2 (IGF2) Signaling in Colorectal Cancer-From Basic Research to Potential Clinical Applications.
Kasprzak A; Adamek A
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31623387
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy-Activated Cancer-Associated Fibroblasts Promote Tumor Progression through Paracrine IGF1R Activation.
Tommelein J; De Vlieghere E; Verset L; Melsens E; Leenders J; Descamps B; Debucquoy A; Vanhove C; Pauwels P; Gespach CP; Vral A; De Boeck A; Haustermans K; de Tullio P; Ceelen W; Demetter P; Boterberg T; Bracke M; De Wever O
Cancer Res; 2018 Feb; 78(3):659-670. PubMed ID: 29217764
[TBL] [Abstract][Full Text] [Related]
6. Carcinoma of the colon and rectum with deregulation of insulin-like growth factor 2 signaling: clinical and molecular implications.
Belharazem D; Magdeburg J; Berton AK; Beissbarth L; Sauer C; Sticht C; Marx A; Hofheinz R; Post S; Kienle P; Ströbel P
J Gastroenterol; 2016 Oct; 51(10):971-84. PubMed ID: 26984550
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor 2 axis supports the serum-independent growth of malignant rhabdoid tumor and is activated by microenvironment stress.
Li T; Wang J; Liu P; Chi J; Yan H; Lei L; Li Z; Yang B; Wang X
Oncotarget; 2017 Jul; 8(29):47269-47283. PubMed ID: 28521298
[TBL] [Abstract][Full Text] [Related]
8. The impact of stromal Hic-5 on the tumorigenesis of colorectal cancer through lysyl oxidase induction and stromal remodeling.
Omoto T; Kim-Kaneyama JR; Lei XF; Orimo A; Ohnishi K; Yoshihara K; Miyauchi A; Li S; Gao L; Umemoto T; Tanaka J; Nakahara K; Takeya M; Ishida F; Kudo SE; Haraguchi S; Miyazaki T; Miyazaki A
Oncogene; 2018 Mar; 37(9):1205-1219. PubMed ID: 29242607
[TBL] [Abstract][Full Text] [Related]
9. Colorectal cancer cell-derived exosomes containing miR-10b regulate fibroblast cells via the PI3K/Akt pathway.
Dai G; Yao X; Zhang Y; Gu J; Geng Y; Xue F; Zhang J
Bull Cancer; 2018 Apr; 105(4):336-349. PubMed ID: 29496262
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor receptor 2/AKT and ERK signaling pathways contribute to the switch from fibroblasts to CAFs by progranulin in microenvironment of colorectal cancer.
Wang L; Yang D; Tian J; Gao A; Shen Y; Ren X; Li X; Jiang G; Dong T
Oncotarget; 2017 Apr; 8(16):26323-26333. PubMed ID: 28412748
[TBL] [Abstract][Full Text] [Related]
11. The IGF2/IR/IGF1R Pathway in Tumor Cells and Myofibroblasts Mediates Resistance to EGFR Inhibition in Cholangiocarcinoma.
Vaquero J; Lobe C; Tahraoui S; Clapéron A; Mergey M; Merabtene F; Wendum D; Coulouarn C; Housset C; Desbois-Mouthon C; Praz F; Fouassier L
Clin Cancer Res; 2018 Sep; 24(17):4282-4296. PubMed ID: 29716918
[No Abstract] [Full Text] [Related]
12. MiR-185 enhances radiosensitivity of colorectal cancer cells by targeting IGF1R and IGF2.
Afshar S; Najafi R; Sedighi Pashaki A; Sharifi M; Nikzad S; Gholami MH; Khoshghadam A; Amini R; Karimi J; Saidijam M
Biomed Pharmacother; 2018 Oct; 106():763-769. PubMed ID: 29990869
[TBL] [Abstract][Full Text] [Related]
13. Paracrine recruitment and activation of fibroblasts by c-Myc expressing breast epithelial cells through the IGFs/IGF-1R axis.
De Vincenzo A; Belli S; Franco P; Telesca M; Iaccarino I; Botti G; Carriero MV; Ranson M; Stoppelli MP
Int J Cancer; 2019 Nov; 145(10):2827-2839. PubMed ID: 31381136
[TBL] [Abstract][Full Text] [Related]
14. The IGF1R/INSR Inhibitor BI 885578 Selectively Inhibits Growth of IGF2-Overexpressing Colorectal Cancer Tumors and Potentiates the Efficacy of Anti-VEGF Therapy.
Sanderson MP; Hofmann MH; Garin-Chesa P; Schweifer N; Wernitznig A; Fischer S; Jeschko A; Meyer R; Moll J; Pecina T; Arnhof H; Weyer-Czernilofsky U; Zahn SK; Adolf GR; Kraut N
Mol Cancer Ther; 2017 Oct; 16(10):2223-2233. PubMed ID: 28729397
[TBL] [Abstract][Full Text] [Related]
15. Interaction between IGF2-PI3K axis and cancer-associated-fibroblasts promotes anal squamous carcinogenesis.
Cacheux W; Lièvre A; Richon S; Vacher S; El Alam E; Briaux A; El Botty R; Mariani P; Buecher B; Schnitzler A; Barbazan J; Roman-Roman S; Bièche I; Dangles-Marie V
Int J Cancer; 2019 Oct; 145(7):1852-1859. PubMed ID: 30714617
[TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer-associated fibroblasts promote metastasis by up-regulating LRG1 through stromal IL-6/STAT3 signaling.
Zhong B; Cheng B; Huang X; Xiao Q; Niu Z; Chen YF; Yu Q; Wang W; Wu XJ
Cell Death Dis; 2021 Dec; 13(1):16. PubMed ID: 34930899
[TBL] [Abstract][Full Text] [Related]
17. The Origin and Contribution of Cancer-Associated Fibroblasts in Colorectal Carcinogenesis.
Kobayashi H; Gieniec KA; Lannagan TRM; Wang T; Asai N; Mizutani Y; Iida T; Ando R; Thomas EM; Sakai A; Suzuki N; Ichinose M; Wright JA; Vrbanac L; Ng JQ; Goyne J; Radford G; Lawrence MJ; Sammour T; Hayakawa Y; Klebe S; Shin AE; Asfaha S; Bettington ML; Rieder F; Arpaia N; Danino T; Butler LM; Burt AD; Leedham SJ; Rustgi AK; Mukherjee S; Takahashi M; Wang TC; Enomoto A; Woods SL; Worthley DL
Gastroenterology; 2022 Mar; 162(3):890-906. PubMed ID: 34883119
[TBL] [Abstract][Full Text] [Related]
18. Asporin promotes pancreatic cancer cell invasion and migration by regulating the epithelial-to-mesenchymal transition (EMT) through both autocrine and paracrine mechanisms.
Wang L; Wu H; Wang L; Zhang H; Lu J; Liang Z; Liu T
Cancer Lett; 2017 Jul; 398():24-36. PubMed ID: 28400334
[TBL] [Abstract][Full Text] [Related]
19. IGF2-derived miR-483 mediated oncofunction by suppressing DLC-1 and associated with colorectal cancer.
Cui H; Liu Y; Jiang J; Liu Y; Yang Z; Wu S; Cao W; Cui IH; Yu C
Oncotarget; 2016 Jul; 7(30):48456-48466. PubMed ID: 27366946
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic Fusion Gene CD74-NRG1 Confers Cancer Stem Cell-like Properties in Lung Cancer through a IGF2 Autocrine/Paracrine Circuit.
Murayama T; Nakaoku T; Enari M; Nishimura T; Tominaga K; Nakata A; Tojo A; Sugano S; Kohno T; Gotoh N
Cancer Res; 2016 Feb; 76(4):974-83. PubMed ID: 26837769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
